Allogeneic stem cell transplantation combined with conditioning regimen including donor-derived CAR-T cells for refractory/relapsed B-cell lymphoma

Bone Marrow Transplant. 2023 Apr;58(4):440-442. doi: 10.1038/s41409-022-01903-3. Epub 2022 Dec 22.

Authors

Fan Yang¹, Hui Shi¹, Teng Xu¹, Rui Liu¹, Yang Lei¹, Ruiting Li¹, Biping Deng², Tong Wu³, Xiaoyan Ke¹, Kai Hu⁴

Affiliations

¹ Department of Adult Lymphoma, Beijing Boren Hospital, Beijing, China.
² Cytology Laboratory, Beijing Boren Hospital, Beijing, China.
³ Department of Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China.
⁴ Department of Adult Lymphoma, Beijing Boren Hospital, Beijing, China. huk@gobroadhealthcare.com.

No abstract available

Publication types

Letter

MeSH terms

Disease-Free Survival
Hematopoietic Stem Cell Transplantation*
Humans
Immunotherapy, Adoptive
Lymphoma, B-Cell* / therapy
Neoplasm Recurrence, Local
T-Lymphocytes
Transplantation Conditioning

Associated data

ChiCTR/ChiCTR2000040665